IVF Hartmann Holding AG (SWX:VBSN)
Switzerland · Delayed Price · Currency is CHF 137.50
-1.00 (-0.72%)
Sep 30, 2025, 4:15 PM CET
IVF Hartmann Holding AG Revenue
In the year 2024, IVF Hartmann Holding AG had annual revenue of 159.03M CHF with 7.23% growth. IVF Hartmann Holding AG had revenue of 82.52M in the half year ending December 31, 2024, with 5.47% growth.
Revenue
159.03M
Revenue Growth
+7.23%
P/S Ratio
2.06
Revenue / Employee
589.01K
Employees
270
Market Cap
327.43M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 159.03M | 10.72M | 7.23% |
| Dec 31, 2023 | 148.31M | -2.84M | -1.88% |
| Dec 31, 2022 | 151.15M | 6.35M | 4.38% |
| Dec 31, 2021 | 144.80M | -29.16M | -16.76% |
| Dec 31, 2020 | 173.96M | 34.94M | 25.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.49B |
| Novartis AG | 43.89B |
| Lonza Group AG | 7.09B |
| Galderma Group AG | 3.73B |
| Alcon | 7.97B |
| Sandoz Group AG | 8.42B |
| Straumann Holding AG | 2.58B |
| Sonova Holding AG | 3.87B |